Outcomes of borderline rheumatic heart disease: A prospective cohort study

Geneviève Bertaina1, Bernard Rouchon2, Bertrand Huon2

  • 1INSERMU970, Paris Cardiovascular Research Centre-PARCC, Paris, France.

Insights

Borderline rheumatic heart disease (RHD) in children often remains stable over two years. Consistent diagnosis of borderline RHD may require review by two specialists.

Area of Science:

  • Cardiology
  • Pediatrics
  • Public Health

Background:

  • Systematic echocardiography screening for rheumatic heart disease (RHD) in endemic areas identifies a new category: borderline RHD.
  • The clinical significance and natural progression of borderline RHD require further investigation.

Purpose of the Study:

  • To evaluate the outcomes of children diagnosed with borderline RHD through echocardiographic screening.
  • To understand the natural history and clinical course of borderline RHD in a pediatric population.

Main Methods:

  • Prospective echocardiographic screening for RHD was conducted in 4th-grade schoolchildren (aged 9-10 years) in New Caledonia.
  • Children with borderline RHD, confirmed by two independent cardiologists, were included and followed up for a median of 23 months.

Main Results:

  • Of 8684 screened children, 25 were diagnosed with borderline RHD and followed up.
  • After a median of 23 months, 60% showed stable valvular lesions, and 32% had normal findings.
  • Two children (8%) progressed to definite RHD, with no clinical events reported during the follow-up period.

Conclusions:

  • Borderline RHD identified through systematic screening in high-risk populations generally shows stability over two years.
  • Consistent diagnosis of borderline RHD may necessitate a consensus review by two independent cardiologists.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
717
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
878
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
445
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
401
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.1K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
404